Johnson & Johnson declares $1.30 dividend

* Johnson & Johnson (NYSE:JNJ [https://seekingalpha.com/symbol/JNJ]) declares $1.30/share quarterly dividend [https://seekingalpha.com/pr/20264062-johnson-and-johnson-announces-quarterly-dividend-for-fourth-quarter-2025], in line with previous.
* Forward yield [https://seekingalpha.com/symbol/JNJ/dividends/yield?source=news_bullet] 2.72%
* Payable Dec. 9; for shareholders of record Nov. 25; ex-div Nov. 25.
* See JNJ Dividend Scorecard, Yield Chart, & Dividend Growth. [https://seekingalpha.com/symbol/JNJ/dividends?source=news_bullet]

MORE ON JOHNSON & JOHNSON

* Johnson & Johnson To Acquire Protagonist? It'd Be A Good Deal To Make [https://seekingalpha.com/article/4829332-johnson-and-johnson-to-acquire-protagonist-itd-be-good-deal-to-make]
* Johnson & Johnson: A Safe Haven That's Quietly Becoming A Bit Overpriced [https://seekingalpha.com/article/4829076-johnson-and-johnson-safe-haven-quietly-becoming-overpriced]
* Johnson & Johnson (JNJ) Presents at Bernstein 2nd Annual Global Healthcare Conference Transcript [https://seekingalpha.com/article/4825596-johnson-and-johnson-jnj-presents-at-bernstein-2nd-annual-global-healthcare-conference]
* Johnson & Johnson rises after reporting Q3 results, raises FY guidance [https://seekingalpha.com/news/4503798-johnson-johnson-reports-q3-results-raises-fy-guidance]
* Protagonist Therapeutics falls amid a report J&J deal price may be lower [https://seekingalpha.com/news/4503679-protagonist-therapeutics-falls-amid-a-report-jj-deal-price-may-be-lower]